Back

Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control

30 August 2024 (11:22 - 11:37)
Organised by: Logo
Congress Presentation Part of: HOT LINE 1 Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Johanne Silvain

Pitie-Salpetriere Hospital (APHP) - Sorbonne University, Paris (France)

8 More presentations in this session

Presentation thumbnail
HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Discussant review - HELIOS-B
Doctor S. Cuddy (Boston, US)
Slides Video
Presentation thumbnail
Panel discussion - HELIOS-B
Video
Presentation thumbnail
Discussant review - ABYSS
Professor J. Armitage (Oxford, GB)
Slides Video
Presentation thumbnail
Panel discussion - ABYSS
Video

Access the full session

Session thumbnail
HOT LINE 1
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 11:22 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 3
30 August 2025
thumbnail
Congress Presentation
Hot Lines from ESC Congress 2024: what is new in cardiology?
31 August 2024
thumbnail
Congress Presentation
Highlights from the ABYSS trial – beta blocker interruption in patients with prior myocardial infarction: implications for clinical practice
30 August 2024
thumbnail
Congress Session
Ask the Trialist - ABYSS
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources